$BLUE Insider Trading
FREE EMAIL WATCHDOG
Get free email notifications about insider trading in bluebird bio, Inc..
- Your email is safe with us.
- The service is free and you can unsubscribe at any time.
General | Insiders | Insider Transactions | Monthly Overview | Weekly Overview
Overview of all insider trading transactions in bluebird bio, Inc.. Get notifications about new insider transactions in bluebird bio, Inc. for free.
Page: < prev 1 ... 2 3 4 5 6 7 8 9 ... 13 next >
Date | Ticker | Company | Owner | Relationship | Transaction | Code | Cost ($) | Shares | Transaction Value ($) | Total Shares | % Holdings |
---|---|---|---|---|---|---|---|---|---|---|---|
May 04 2018 | BLUE | bluebird bio, Inc. | Davidson David | Chief Medical Offic ... | Sell | S | 179.00 | 1,200 | 214,795 | 28,603 | 29.8 K to 28.6 K (-4.03 %) |
May 04 2018 | BLUE | bluebird bio, Inc. | Davidson David | Chief Medical Offic ... | Sell | S | 177.90 | 3,299 | 586,880 | 29,803 | 33.1 K to 29.8 K (-9.97 %) |
May 04 2018 | BLUE | bluebird bio, Inc. | Davidson David | Chief Medical Offic ... | Sell | S | 176.55 | 1,000 | 176,546 | 33,102 | 34.1 K to 33.1 K (-2.93 %) |
May 04 2018 | BLUE | bluebird bio, Inc. | Davidson David | Chief Medical Offic ... | Sell | S | 175.61 | 1,703 | 299,058 | 34,102 | 35.8 K to 34.1 K (-4.76 %) |
May 04 2018 | BLUE | bluebird bio, Inc. | Davidson David | Chief Medical Offic ... | Sell | S | 174.41 | 1,000 | 174,405 | 35,805 | 36.8 K to 35.8 K (-2.72 %) |
May 04 2018 | BLUE | bluebird bio, Inc. | Davidson David | Chief Medical Offic ... | Sell | S | 173.25 | 1,100 | 190,570 | 36,805 | 37.9 K to 36.8 K (-2.90 %) |
May 04 2018 | BLUE | bluebird bio, Inc. | Davidson David | Chief Medical Offic ... | Buy | M | 24.47 | 13,000 | 318,110 | 37,905 | 24.9 K to 37.9 K (+52.20 %) |
Apr 16 2018 | BLUE | bluebird bio, Inc. | Davidson David | Chief Medical Offic ... | Option Exercise | M | 24.47 | 3,000 | 73,410 | 40,000 | |
Apr 16 2018 | BLUE | bluebird bio, Inc. | Davidson David | Chief Medical Offic ... | Sell | S | 180.17 | 3,000 | 540,508 | 24,905 | 27.9 K to 24.9 K (-10.75 %) |
Apr 16 2018 | BLUE | bluebird bio, Inc. | Davidson David | Chief Medical Offic ... | Buy | M | 24.47 | 3,000 | 73,410 | 27,905 | 24.9 K to 27.9 K (+12.05 %) |
Apr 04 2018 | BLUE | bluebird bio, Inc. | Gregory Philip D | Chief Scientific Of ... | Option Exercise | M | 50.51 | 1,250 | 63,138 | 17,000 | |
Apr 04 2018 | BLUE | bluebird bio, Inc. | Gregory Philip D | Chief Scientific Of ... | Sell | S | 170.50 | 700 | 119,350 | 29,272 | 30 K to 29.3 K (-2.34 %) |
Apr 04 2018 | BLUE | bluebird bio, Inc. | Gregory Philip D | Chief Scientific Of ... | Sell | S | 169.02 | 300 | 50,705 | 29,972 | 30.3 K to 30 K (-0.99 %) |
Apr 04 2018 | BLUE | bluebird bio, Inc. | Gregory Philip D | Chief Scientific Of ... | Sell | S | 167.64 | 1,250 | 209,553 | 30,272 | 31.5 K to 30.3 K (-3.97 %) |
Apr 04 2018 | BLUE | bluebird bio, Inc. | Gregory Philip D | Chief Scientific Of ... | Buy | M | 50.51 | 1,250 | 63,138 | 31,522 | 30.3 K to 31.5 K (+4.13 %) |
Apr 04 2018 | BLUE | bluebird bio, Inc. | Davidson David | Chief Medical Offic ... | Option Exercise | M | 24.47 | 22,000 | 538,340 | 43,000 | |
Apr 04 2018 | BLUE | bluebird bio, Inc. | Davidson David | Chief Medical Offic ... | Sell | S | 171.33 | 1,600 | 274,135 | 24,905 | 26.5 K to 24.9 K (-6.04 %) |
Apr 04 2018 | BLUE | bluebird bio, Inc. | Davidson David | Chief Medical Offic ... | Sell | S | 170.55 | 3,552 | 605,809 | 26,505 | 30.1 K to 26.5 K (-11.82 %) |
Apr 04 2018 | BLUE | bluebird bio, Inc. | Davidson David | Chief Medical Offic ... | Sell | S | 169.36 | 3,800 | 643,552 | 30,057 | 33.9 K to 30.1 K (-11.22 %) |
Apr 04 2018 | BLUE | bluebird bio, Inc. | Davidson David | Chief Medical Offic ... | Sell | S | 168.09 | 1,900 | 319,375 | 33,857 | 35.8 K to 33.9 K (-5.31 %) |
Apr 04 2018 | BLUE | bluebird bio, Inc. | Davidson David | Chief Medical Offic ... | Sell | S | 167.21 | 3,400 | 568,529 | 35,757 | 39.2 K to 35.8 K (-8.68 %) |
Apr 04 2018 | BLUE | bluebird bio, Inc. | Davidson David | Chief Medical Offic ... | Sell | S | 166.18 | 1,518 | 252,265 | 39,157 | 40.7 K to 39.2 K (-3.73 %) |
Apr 04 2018 | BLUE | bluebird bio, Inc. | Davidson David | Chief Medical Offic ... | Sell | S | 164.66 | 2,375 | 391,074 | 40,675 | 43.1 K to 40.7 K (-5.52 %) |
Apr 04 2018 | BLUE | bluebird bio, Inc. | Davidson David | Chief Medical Offic ... | Sell | S | 163.86 | 2,900 | 475,201 | 43,050 | 46 K to 43.1 K (-6.31 %) |
Apr 04 2018 | BLUE | bluebird bio, Inc. | Davidson David | Chief Medical Offic ... | Sell | S | 162.77 | 955 | 155,446 | 45,950 | 46.9 K to 46 K (-2.04 %) |
Apr 04 2018 | BLUE | bluebird bio, Inc. | Davidson David | Chief Medical Offic ... | Buy | M | 24.47 | 22,000 | 538,340 | 46,905 | 24.9 K to 46.9 K (+88.34 %) |
Mar 19 2018 | BLUE | bluebird bio, Inc. | Vachon Mark | Director | Option Exercise | M | 30.47 | 6,000 | 182,820 | 2,000 | |
Mar 19 2018 | BLUE | bluebird bio, Inc. | Vachon Mark | Director | Sell | S | 220.20 | 300 | 66,060 | 1,000 | 1.3 K to 1,000 (-23.08 %) |
Mar 19 2018 | BLUE | bluebird bio, Inc. | Vachon Mark | Director | Sell | S | 217.24 | 400 | 86,895 | 1,300 | 1.7 K to 1.3 K (-23.53 %) |
Mar 19 2018 | BLUE | bluebird bio, Inc. | Vachon Mark | Director | Sell | S | 215.84 | 1,200 | 259,003 | 1,700 | 2.9 K to 1.7 K (-41.38 %) |
Mar 19 2018 | BLUE | bluebird bio, Inc. | Vachon Mark | Director | Sell | S | 214.76 | 1,600 | 343,610 | 2,900 | 4.5 K to 2.9 K (-35.56 %) |
Mar 19 2018 | BLUE | bluebird bio, Inc. | Vachon Mark | Director | Sell | S | 213.61 | 550 | 117,487 | 4,500 | 5.1 K to 4.5 K (-10.89 %) |
Mar 19 2018 | BLUE | bluebird bio, Inc. | Vachon Mark | Director | Sell | S | 212.72 | 950 | 202,087 | 5,050 | 6 K to 5.1 K (-15.83 %) |
Mar 19 2018 | BLUE | bluebird bio, Inc. | Vachon Mark | Director | Sell | S | 211.11 | 1,000 | 211,108 | 6,000 | 7 K to 6 K (-14.29 %) |
Mar 19 2018 | BLUE | bluebird bio, Inc. | Vachon Mark | Director | Buy | M | 30.47 | 6,000 | 182,820 | 7,000 | 1,000 to 7 K (+600.00 %) |
Mar 05 2018 | BLUE | bluebird bio, Inc. | Gregory Philip D | Chief Scientific Of ... | Option Exercise | M | 50.51 | 1,250 | 63,138 | 18,250 | |
Mar 05 2018 | BLUE | bluebird bio, Inc. | Gregory Philip D | Chief Scientific Of ... | Sell | S | 201.58 | 74 | 14,917 | 30,272 | 30.3 K to 30.3 K (-0.24 %) |
Mar 05 2018 | BLUE | bluebird bio, Inc. | Gregory Philip D | Chief Scientific Of ... | Sell | S | 200.85 | 400 | 80,340 | 30,346 | 30.7 K to 30.3 K (-1.30 %) |
Mar 05 2018 | BLUE | bluebird bio, Inc. | Gregory Philip D | Chief Scientific Of ... | Sell | S | 199.88 | 1,576 | 315,009 | 30,746 | 32.3 K to 30.7 K (-4.88 %) |
Mar 05 2018 | BLUE | bluebird bio, Inc. | Gregory Philip D | Chief Scientific Of ... | Sell | S | 198.65 | 200 | 39,730 | 32,322 | 32.5 K to 32.3 K (-0.61 %) |
Mar 05 2018 | BLUE | bluebird bio, Inc. | Gregory Philip D | Chief Scientific Of ... | Buy | M | 50.51 | 1,250 | 63,138 | 32,522 | 31.3 K to 32.5 K (+4.00 %) |
Mar 02 2018 | BLUE | bluebird bio, Inc. | HIGH SUSANNA GATTI | Chief Operating Off ... | Option Exercise | M | 68.65 | 1,044 | 71,671 | 44,162 | |
Mar 02 2018 | BLUE | bluebird bio, Inc. | HIGH SUSANNA GATTI | Chief Operating Off ... | Sell | S | 203.03 | 644 | 130,752 | 17,500 | 18.1 K to 17.5 K (-3.55 %) |
Mar 02 2018 | BLUE | bluebird bio, Inc. | HIGH SUSANNA GATTI | Chief Operating Off ... | Sell | S | 202.10 | 400 | 80,840 | 18,144 | 18.5 K to 18.1 K (-2.16 %) |
Mar 02 2018 | BLUE | bluebird bio, Inc. | HIGH SUSANNA GATTI | Chief Operating Off ... | Buy | M | 68.65 | 1,044 | 71,671 | 18,544 | 17.5 K to 18.5 K (+5.97 %) |
Feb 05 2018 | BLUE | bluebird bio, Inc. | Walsh Jeffrey T. | Chief Financial | Option Exercise | A | 205.25 | 45,000 | 9,236,250 | 45,000 | |
Feb 05 2018 | BLUE | bluebird bio, Inc. | Walsh Jeffrey T. | Chief Financial | Grant | A | 0.00 | 11,250 | 0 | 35,495 | 24.2 K to 35.5 K (+46.40 %) |
Feb 05 2018 | BLUE | bluebird bio, Inc. | HIGH SUSANNA GATTI | Chief Operating Off ... | Option Exercise | A | 205.25 | 25,000 | 5,131,250 | 25,000 | |
Feb 05 2018 | BLUE | bluebird bio, Inc. | HIGH SUSANNA GATTI | Chief Operating Off ... | Grant | A | 0.00 | 6,250 | 0 | 17,500 | 11.3 K to 17.5 K (+55.56 %) |
Feb 05 2018 | BLUE | bluebird bio, Inc. | Leschly Nick | President and CEO | Option Exercise | A | 205.25 | 120,000 | 24,630,000 | 120,000 | |
Feb 05 2018 | BLUE | bluebird bio, Inc. | Leschly Nick | President and CEO | Grant | A | 0.00 | 30,000 | 0 | 200,577 | 170.6 K to 200.6 K (+17.59 %) |
Feb 05 2018 | BLUE | bluebird bio, Inc. | Gregory Philip D | Chief Scientific Of ... | Option Exercise | M | 50.51 | 1,250 | 63,138 | 19,500 | |
Feb 05 2018 | BLUE | bluebird bio, Inc. | Gregory Philip D | Chief Scientific Of ... | Option Exercise | A | 205.25 | 34,000 | 6,978,500 | 34,000 | |
Feb 05 2018 | BLUE | bluebird bio, Inc. | Gregory Philip D | Chief Scientific Of ... | Sell | S | 206.12 | 749 | 154,387 | 31,272 | 32 K to 31.3 K (-2.34 %) |
Feb 05 2018 | BLUE | bluebird bio, Inc. | Gregory Philip D | Chief Scientific Of ... | Sell | S | 205.23 | 800 | 164,180 | 32,021 | 32.8 K to 32 K (-2.44 %) |
Feb 05 2018 | BLUE | bluebird bio, Inc. | Gregory Philip D | Chief Scientific Of ... | Sell | S | 203.73 | 400 | 81,490 | 32,821 | 33.2 K to 32.8 K (-1.20 %) |
Feb 05 2018 | BLUE | bluebird bio, Inc. | Gregory Philip D | Chief Scientific Of ... | Sell | S | 202.54 | 301 | 60,963 | 33,221 | 33.5 K to 33.2 K (-0.90 %) |
Feb 05 2018 | BLUE | bluebird bio, Inc. | Gregory Philip D | Chief Scientific Of ... | Buy | M | 50.51 | 1,250 | 63,138 | 33,522 | 32.3 K to 33.5 K (+3.87 %) |
Feb 05 2018 | BLUE | bluebird bio, Inc. | Gregory Philip D | Chief Scientific Of ... | Grant | A | 0.00 | 8,500 | 0 | 32,272 | 23.8 K to 32.3 K (+35.76 %) |
Feb 05 2018 | BLUE | bluebird bio, Inc. | Davidson David | Chief Medical Offic ... | Option Exercise | M | 5.50 | 4,000 | 22,002 | 67,951 | |
Feb 05 2018 | BLUE | bluebird bio, Inc. | Davidson David | Chief Medical Offic ... | Option Exercise | A | 205.25 | 45,000 | 9,236,250 | 45,000 | |
Feb 05 2018 | BLUE | bluebird bio, Inc. | Davidson David | Chief Medical Offic ... | Sell | S | 203.20 | 1,400 | 284,484 | 24,905 | 26.3 K to 24.9 K (-5.32 %) |
Feb 05 2018 | BLUE | bluebird bio, Inc. | Davidson David | Chief Medical Offic ... | Sell | S | 201.91 | 2,600 | 524,957 | 26,305 | 28.9 K to 26.3 K (-8.99 %) |
Feb 05 2018 | BLUE | bluebird bio, Inc. | Davidson David | Chief Medical Offic ... | Buy | M | 5.50 | 4,000 | 22,002 | 28,905 | 24.9 K to 28.9 K (+16.06 %) |
Feb 05 2018 | BLUE | bluebird bio, Inc. | Davidson David | Chief Medical Offic ... | Grant | A | 0.00 | 11,250 | 0 | 24,905 | 13.7 K to 24.9 K (+82.39 %) |
Feb 05 2018 | BLUE | bluebird bio, Inc. | Cole Jason | Chief Legal Officer | Option Exercise | A | 205.25 | 25,000 | 5,131,250 | 25,000 | |
Feb 05 2018 | BLUE | bluebird bio, Inc. | Cole Jason | Chief Legal Officer | Grant | A | 0.00 | 6,250 | 0 | 26,048 | 19.8 K to 26 K (+31.57 %) |
Feb 01 2018 | BLUE | bluebird bio, Inc. | HIGH SUSANNA GATTI | Chief Operating Off ... | Option Exercise | M | 68.65 | 14,794 | 1,015,608 | 45,206 | |
Feb 01 2018 | BLUE | bluebird bio, Inc. | HIGH SUSANNA GATTI | Chief Operating Off ... | Sell | S | 203.60 | 82 | 16,695 | 11,250 | 11.3 K to 11.3 K (-0.72 %) |
Feb 01 2018 | BLUE | bluebird bio, Inc. | HIGH SUSANNA GATTI | Chief Operating Off ... | Sell | S | 202.68 | 204 | 41,347 | 11,332 | 11.5 K to 11.3 K (-1.77 %) |
Feb 01 2018 | BLUE | bluebird bio, Inc. | HIGH SUSANNA GATTI | Chief Operating Off ... | Sell | S | 201.57 | 770 | 155,212 | 11,536 | 12.3 K to 11.5 K (-6.26 %) |
Feb 01 2018 | BLUE | bluebird bio, Inc. | HIGH SUSANNA GATTI | Chief Operating Off ... | Sell | S | 200.88 | 733 | 147,246 | 12,306 | 13 K to 12.3 K (-5.62 %) |
Feb 01 2018 | BLUE | bluebird bio, Inc. | HIGH SUSANNA GATTI | Chief Operating Off ... | Sell | S | 199.43 | 697 | 139,004 | 13,039 | 13.7 K to 13 K (-5.07 %) |
Feb 01 2018 | BLUE | bluebird bio, Inc. | HIGH SUSANNA GATTI | Chief Operating Off ... | Sell | S | 198.46 | 490 | 97,247 | 13,736 | 14.2 K to 13.7 K (-3.44 %) |
Feb 01 2018 | BLUE | bluebird bio, Inc. | HIGH SUSANNA GATTI | Chief Operating Off ... | Sell | S | 197.61 | 1,385 | 273,685 | 14,226 | 15.6 K to 14.2 K (-8.87 %) |
Feb 01 2018 | BLUE | bluebird bio, Inc. | HIGH SUSANNA GATTI | Chief Operating Off ... | Sell | S | 196.63 | 1,702 | 334,671 | 15,611 | 17.3 K to 15.6 K (-9.83 %) |
Feb 01 2018 | BLUE | bluebird bio, Inc. | HIGH SUSANNA GATTI | Chief Operating Off ... | Sell | S | 195.57 | 2,039 | 398,761 | 17,313 | 19.4 K to 17.3 K (-10.54 %) |
Feb 01 2018 | BLUE | bluebird bio, Inc. | HIGH SUSANNA GATTI | Chief Operating Off ... | Sell | S | 194.65 | 4,657 | 906,497 | 19,352 | 24 K to 19.4 K (-19.40 %) |
Feb 01 2018 | BLUE | bluebird bio, Inc. | HIGH SUSANNA GATTI | Chief Operating Off ... | Sell | S | 193.74 | 3,703 | 717,434 | 24,009 | 27.7 K to 24 K (-13.36 %) |
Feb 01 2018 | BLUE | bluebird bio, Inc. | HIGH SUSANNA GATTI | Chief Operating Off ... | Sell | S | 192.49 | 800 | 153,994 | 27,712 | 28.5 K to 27.7 K (-2.81 %) |
Feb 01 2018 | BLUE | bluebird bio, Inc. | HIGH SUSANNA GATTI | Chief Operating Off ... | Buy | M | 68.65 | 14,794 | 1,015,608 | 28,512 | 13.7 K to 28.5 K (+107.84 %) |
Feb 01 2018 | BLUE | bluebird bio, Inc. | Cole Jason | Chief Legal Officer | Option Exercise | M | 22.53 | 25,000 | 563,250 | 6,686 | |
Feb 01 2018 | BLUE | bluebird bio, Inc. | Cole Jason | Chief Legal Officer | Sell | S | 203.60 | 118 | 24,025 | 19,798 | 19.9 K to 19.8 K (-0.59 %) |
Feb 01 2018 | BLUE | bluebird bio, Inc. | Cole Jason | Chief Legal Officer | Sell | S | 202.68 | 296 | 59,993 | 19,916 | 20.2 K to 19.9 K (-1.46 %) |
Feb 01 2018 | BLUE | bluebird bio, Inc. | Cole Jason | Chief Legal Officer | Sell | S | 201.57 | 1,113 | 224,352 | 20,212 | 21.3 K to 20.2 K (-5.22 %) |
Feb 01 2018 | BLUE | bluebird bio, Inc. | Cole Jason | Chief Legal Officer | Sell | S | 200.88 | 1,062 | 213,336 | 21,325 | 22.4 K to 21.3 K (-4.74 %) |
Feb 01 2018 | BLUE | bluebird bio, Inc. | Cole Jason | Chief Legal Officer | Sell | S | 199.43 | 1,003 | 200,031 | 22,387 | 23.4 K to 22.4 K (-4.29 %) |
Feb 01 2018 | BLUE | bluebird bio, Inc. | Cole Jason | Chief Legal Officer | Sell | S | 198.46 | 710 | 140,908 | 23,390 | 24.1 K to 23.4 K (-2.95 %) |
Feb 01 2018 | BLUE | bluebird bio, Inc. | Cole Jason | Chief Legal Officer | Sell | S | 197.61 | 2,027 | 400,548 | 24,100 | 26.1 K to 24.1 K (-7.76 %) |
Feb 01 2018 | BLUE | bluebird bio, Inc. | Cole Jason | Chief Legal Officer | Sell | S | 196.63 | 2,458 | 483,325 | 26,127 | 28.6 K to 26.1 K (-8.60 %) |
Feb 01 2018 | BLUE | bluebird bio, Inc. | Cole Jason | Chief Legal Officer | Sell | S | 195.57 | 2,951 | 577,116 | 28,585 | 31.5 K to 28.6 K (-9.36 %) |
Feb 01 2018 | BLUE | bluebird bio, Inc. | Cole Jason | Chief Legal Officer | Sell | S | 194.65 | 6,743 | 1,312,543 | 31,536 | 38.3 K to 31.5 K (-17.62 %) |
Feb 01 2018 | BLUE | bluebird bio, Inc. | Cole Jason | Chief Legal Officer | Sell | S | 193.74 | 5,359 | 1,038,275 | 38,279 | 43.6 K to 38.3 K (-12.28 %) |
Feb 01 2018 | BLUE | bluebird bio, Inc. | Cole Jason | Chief Legal Officer | Sell | S | 192.49 | 1,160 | 223,290 | 43,638 | 44.8 K to 43.6 K (-2.59 %) |
Feb 01 2018 | BLUE | bluebird bio, Inc. | Cole Jason | Chief Legal Officer | Buy | M | 22.53 | 25,000 | 563,250 | 44,798 | 19.8 K to 44.8 K (+126.28 %) |
Jan 09 2018 | BLUE | bluebird bio, Inc. | Walsh Jeffrey T. | Chief Financial | Sell | S | 174.17 | 401 | 69,842 | 24,245 | 24.6 K to 24.2 K (-1.63 %) |
Jan 09 2018 | BLUE | bluebird bio, Inc. | Walsh Jeffrey T. | Chief Financial | Sell | S | 173.26 | 2,659 | 460,688 | 24,646 | 27.3 K to 24.6 K (-9.74 %) |
Jan 09 2018 | BLUE | bluebird bio, Inc. | Leschly Nick | President and CEO | Sell | S | 174.17 | 712 | 124,009 | 170,297 | 171 K to 170.3 K (-0.42 %) |
Jan 09 2018 | BLUE | bluebird bio, Inc. | Leschly Nick | President and CEO | Sell | S | 173.26 | 4,723 | 818,289 | 171,009 | 175.7 K to 171 K (-2.69 %) |
Jan 09 2018 | BLUE | bluebird bio, Inc. | Gregory Philip D | Chief Scientific Of ... | Sell | S | 174.17 | 223 | 38,840 | 23,772 | 24 K to 23.8 K (-0.93 %) |
Jan 09 2018 | BLUE | bluebird bio, Inc. | Gregory Philip D | Chief Scientific Of ... | Sell | S | 173.26 | 1,489 | 257,980 | 23,995 | 25.5 K to 24 K (-5.84 %) |
Jan 09 2018 | BLUE | bluebird bio, Inc. | Davidson David | Chief Medical Offic ... | Option Exercise | M | 5.50 | 1,200 | 6,600 | 71,951 | |
Jan 09 2018 | BLUE | bluebird bio, Inc. | Davidson David | Chief Medical Offic ... | Sell | S | 174.60 | 1,000 | 174,600 | 13,655 | 14.7 K to 13.7 K (-6.82 %) |
Jan 09 2018 | BLUE | bluebird bio, Inc. | Davidson David | Chief Medical Offic ... | Sell | S | 171.42 | 200 | 34,283 | 14,655 | 14.9 K to 14.7 K (-1.35 %) |
Jan 09 2018 | BLUE | bluebird bio, Inc. | Davidson David | Chief Medical Offic ... | Buy | M | 5.50 | 1,200 | 6,600 | 14,855 | 13.7 K to 14.9 K (+8.79 %) |
Jan 09 2018 | BLUE | bluebird bio, Inc. | Davidson David | Chief Medical Offic ... | Sell | S | 174.17 | 304 | 52,947 | 13,655 | 14 K to 13.7 K (-2.18 %) |
Jan 09 2018 | BLUE | bluebird bio, Inc. | Davidson David | Chief Medical Offic ... | Sell | S | 173.26 | 2,018 | 349,631 | 13,959 | 16 K to 14 K (-12.63 %) |
Jan 09 2018 | BLUE | bluebird bio, Inc. | Cole Jason | Chief Legal Officer | Sell | S | 174.17 | 147 | 25,603 | 19,798 | 19.9 K to 19.8 K (-0.74 %) |
Jan 09 2018 | BLUE | bluebird bio, Inc. | Cole Jason | Chief Legal Officer | Sell | S | 173.26 | 982 | 170,138 | 19,945 | 20.9 K to 19.9 K (-4.69 %) |
Jan 05 2018 | BLUE | bluebird bio, Inc. | Gregory Philip D | Chief Scientific Of ... | Option Exercise | M | 50.51 | 1,250 | 63,138 | 20,750 | |
Jan 05 2018 | BLUE | bluebird bio, Inc. | Gregory Philip D | Chief Scientific Of ... | Sell | S | 182.01 | 542 | 98,648 | 25,484 | 26 K to 25.5 K (-2.08 %) |
Jan 05 2018 | BLUE | bluebird bio, Inc. | Gregory Philip D | Chief Scientific Of ... | Sell | S | 180.81 | 400 | 72,325 | 26,026 | 26.4 K to 26 K (-1.51 %) |
Jan 05 2018 | BLUE | bluebird bio, Inc. | Gregory Philip D | Chief Scientific Of ... | Sell | S | 180.11 | 1,308 | 235,577 | 26,426 | 27.7 K to 26.4 K (-4.72 %) |
Jan 05 2018 | BLUE | bluebird bio, Inc. | Gregory Philip D | Chief Scientific Of ... | Buy | M | 50.51 | 1,250 | 63,138 | 27,734 | 26.5 K to 27.7 K (+4.72 %) |
Jan 05 2018 | BLUE | bluebird bio, Inc. | Davidson David | Chief Medical Offic ... | Option Exercise | M | 5.50 | 6,000 | 33,002 | 73,151 | |
Jan 05 2018 | BLUE | bluebird bio, Inc. | Davidson David | Chief Medical Offic ... | Sell | S | 182.36 | 275 | 50,149 | 15,977 | 16.3 K to 16 K (-1.69 %) |
Jan 05 2018 | BLUE | bluebird bio, Inc. | Davidson David | Chief Medical Offic ... | Sell | S | 181.70 | 757 | 137,548 | 16,252 | 17 K to 16.3 K (-4.45 %) |
Jan 05 2018 | BLUE | bluebird bio, Inc. | Davidson David | Chief Medical Offic ... | Sell | S | 180.36 | 2,468 | 445,133 | 17,009 | 19.5 K to 17 K (-12.67 %) |
Jan 05 2018 | BLUE | bluebird bio, Inc. | Davidson David | Chief Medical Offic ... | Sell | S | 179.58 | 2,500 | 448,950 | 19,477 | 22 K to 19.5 K (-11.38 %) |
Jan 05 2018 | BLUE | bluebird bio, Inc. | Davidson David | Chief Medical Offic ... | Buy | M | 5.50 | 6,000 | 33,002 | 21,977 | 16 K to 22 K (+37.55 %) |
Dec 15 2017 | BLUE | bluebird bio, Inc. | Leschly Nick | President and CEO | Option Exercise | M | 5.50 | 37,873 | 208,317 | 203,355 | |
Dec 15 2017 | BLUE | bluebird bio, Inc. | Leschly Nick | President and CEO | Sell | S | 188.49 | 2,530 | 476,881 | 175,732 | 178.3 K to 175.7 K (-1.42 %) |
Dec 15 2017 | BLUE | bluebird bio, Inc. | Leschly Nick | President and CEO | Sell | S | 187.57 | 5,700 | 1,069,135 | 178,262 | 184 K to 178.3 K (-3.10 %) |
Dec 15 2017 | BLUE | bluebird bio, Inc. | Leschly Nick | President and CEO | Sell | S | 186.56 | 12,006 | 2,239,861 | 183,962 | 196 K to 184 K (-6.13 %) |
Dec 15 2017 | BLUE | bluebird bio, Inc. | Leschly Nick | President and CEO | Sell | S | 185.41 | 16,369 | 3,035,040 | 195,968 | 212.3 K to 196 K (-7.71 %) |
Dec 15 2017 | BLUE | bluebird bio, Inc. | Leschly Nick | President and CEO | Sell | S | 184.53 | 18,930 | 3,493,130 | 212,337 | 231.3 K to 212.3 K (-8.19 %) |
Dec 15 2017 | BLUE | bluebird bio, Inc. | Leschly Nick | President and CEO | Sell | S | 183.46 | 19,221 | 3,526,217 | 231,267 | 250.5 K to 231.3 K (-7.67 %) |
Dec 15 2017 | BLUE | bluebird bio, Inc. | Leschly Nick | President and CEO | Sell | S | 182.49 | 27,797 | 5,072,655 | 250,488 | 278.3 K to 250.5 K (-9.99 %) |
Dec 15 2017 | BLUE | bluebird bio, Inc. | Leschly Nick | President and CEO | Sell | S | 181.72 | 14,947 | 2,716,199 | 278,285 | 293.2 K to 278.3 K (-5.10 %) |
Dec 15 2017 | BLUE | bluebird bio, Inc. | Leschly Nick | President and CEO | Buy | M | 5.50 | 37,873 | 208,317 | 293,232 | 255.4 K to 293.2 K (+14.83 %) |
Dec 13 2017 | BLUE | bluebird bio, Inc. | Vachon Mark | Director | Option Exercise | M | 30.47 | 6,000 | 182,820 | 8,000 | |
Dec 13 2017 | BLUE | bluebird bio, Inc. | Vachon Mark | Director | Sell | S | 212.65 | 300 | 63,795 | 1,000 | 1.3 K to 1,000 (-23.08 %) |
Dec 13 2017 | BLUE | bluebird bio, Inc. | Vachon Mark | Director | Sell | S | 219.50 | 1,979 | 434,391 | 1,300 | 3.3 K to 1.3 K (-60.35 %) |
Dec 13 2017 | BLUE | bluebird bio, Inc. | Vachon Mark | Director | Sell | S | 218.06 | 2,200 | 479,740 | 3,279 | 5.5 K to 3.3 K (-40.15 %) |
Dec 13 2017 | BLUE | bluebird bio, Inc. | Vachon Mark | Director | Sell | S | 217.09 | 800 | 173,670 | 5,479 | 6.3 K to 5.5 K (-12.74 %) |
Dec 13 2017 | BLUE | bluebird bio, Inc. | Vachon Mark | Director | Sell | S | 212.32 | 1,421 | 301,700 | 6,279 | 7.7 K to 6.3 K (-18.45 %) |
Dec 13 2017 | BLUE | bluebird bio, Inc. | Vachon Mark | Director | Sell | S | 210.57 | 300 | 63,170 | 7,700 | 8 K to 7.7 K (-3.75 %) |
Dec 13 2017 | BLUE | bluebird bio, Inc. | Vachon Mark | Director | Buy | M | 30.47 | 6,000 | 182,820 | 8,000 | 2 K to 8 K (+300.00 %) |
Dec 13 2017 | BLUE | bluebird bio, Inc. | Walsh Jeffrey T. | Chief Financial | Option Exercise | M | 24.47 | 9,900 | 242,253 | 32,271 | |
Dec 13 2017 | BLUE | bluebird bio, Inc. | Walsh Jeffrey T. | Chief Financial | Sell | S | 221.52 | 1,420 | 314,554 | 27,305 | 28.7 K to 27.3 K (-4.94 %) |
Dec 13 2017 | BLUE | bluebird bio, Inc. | Walsh Jeffrey T. | Chief Financial | Sell | S | 220.52 | 680 | 149,954 | 28,725 | 29.4 K to 28.7 K (-2.31 %) |
Dec 13 2017 | BLUE | bluebird bio, Inc. | Walsh Jeffrey T. | Chief Financial | Sell | S | 219.49 | 800 | 175,588 | 29,405 | 30.2 K to 29.4 K (-2.65 %) |
Dec 13 2017 | BLUE | bluebird bio, Inc. | Walsh Jeffrey T. | Chief Financial | Sell | S | 218.09 | 950 | 207,185 | 30,205 | 31.2 K to 30.2 K (-3.05 %) |
Dec 13 2017 | BLUE | bluebird bio, Inc. | Walsh Jeffrey T. | Chief Financial | Sell | S | 217.33 | 2,550 | 554,196 | 31,155 | 33.7 K to 31.2 K (-7.57 %) |
Dec 13 2017 | BLUE | bluebird bio, Inc. | Walsh Jeffrey T. | Chief Financial | Sell | S | 214.58 | 380 | 81,542 | 33,705 | 34.1 K to 33.7 K (-1.11 %) |
Dec 13 2017 | BLUE | bluebird bio, Inc. | Walsh Jeffrey T. | Chief Financial | Sell | S | 213.65 | 520 | 111,096 | 34,085 | 34.6 K to 34.1 K (-1.50 %) |
Dec 13 2017 | BLUE | bluebird bio, Inc. | Walsh Jeffrey T. | Chief Financial | Sell | S | 212.70 | 1,200 | 255,240 | 34,605 | 35.8 K to 34.6 K (-3.35 %) |
Dec 13 2017 | BLUE | bluebird bio, Inc. | Walsh Jeffrey T. | Chief Financial | Sell | S | 211.06 | 101 | 21,317 | 35,805 | 35.9 K to 35.8 K (-0.28 %) |
Dec 13 2017 | BLUE | bluebird bio, Inc. | Walsh Jeffrey T. | Chief Financial | Sell | S | 210.25 | 1,299 | 273,112 | 35,906 | 37.2 K to 35.9 K (-3.49 %) |
Dec 13 2017 | BLUE | bluebird bio, Inc. | Walsh Jeffrey T. | Chief Financial | Buy | M | 24.47 | 9,900 | 242,253 | 37,205 | 27.3 K to 37.2 K (+36.26 %) |